National and Kapodistrian University of Athens
Μοριακή επιδημιολογία και μελέτη αντοχής στα αντιμυκητιακά, στελεχών Candida σε ασθενείς με σύνδρομο επίκτητης ανοσολογικής ανεπάρκειας (AIDS)
Abstract
dc:descriptionHIV positive patients are susceptible to a wide array of microbial infections. The oral cavity and perioral areas are common anatomical sites that microbial infections affect causing severe mucosal and skin lesions. Oropharyngeal candidiasis (OPC) in HIV-positive individuals is still common, although newer antiretroviral therapies, such as HAART/PI-HAART, had initially a positive impact on limiting erythematous and pseudomembranous candidiasis. The present study aimed at evaluating (a) the influence of newer antiretroviral therapies in the frequency of OPC and their impact on the yeast species responsible, by comparing populations of HIV/AIDS individuals prior to, and after, establishment of HAART; (b) record antifungal susceptibility trends of isolates from patients before and after the introduction of HAART; (c) resolve the molecular base of the most common and prominent resistance patterns. At first, the Candida species OPC infection frequencies was established from 349 AIDS patients in the G. Gennimatas General Hospital Special Infections Unit, followed by recording outcomes of antifungal regimens. The 271 OPC Candida spp. isolated from a total of 665 samples were characterized by standard phenotypic methods comprising microscopy culture and carbohydrate assimilation tests. The in vitro resistance of single colonies to fluconazole, voriconazole, amphotericin B, 5-fluorocytocine, itraconazole, ketoconazole and caspofungin were determined using both E-test and the CLSI reference microdilution method (M27 A2). Successive sampling in 19 patients with recurring candidiasis yielded 32 yeast isolates, of which 22 were C. albicans. This species was prominent in all cases, regardless patients undergoing non-HAART or HAART antiretroviral therapy. Interestingly, Candida non-albicans occurred significantly more frequently (p > 0.5) in high viral load and/or low CD4 counts in patients with OPC. PCR-sequencing of fluconazole-resistant C. albicans isolates revealed homogenous resistance genotypes (MDR-, ACT1+, CDR +, ERG11+), without any point mutations, while resistance within C. albicans isolates was 22,4% compared to 44% for Candida non-albicans isolates, in accordance with international data. Furthermore, the study on C. albicans fluconazole-resistant and fluconazole-susceptible identification of specific subtypes by PFGE-Not1 RFLP showed that fluconazole resistance is not correlated with any specific C. albicans subtype. Overall, C. albicans were found 100% susceptible to voriconazole. As different Candida species show variable susceptibility to antifungals, species level identification of isolates followed by susceptibility testing can assist targeted antifungal therapy in HIV/AIDS patients with OPC, regardless the antiretroviral regimens administered.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Hini, Stavroula
- Χίνη, Σταυρούλα
Subjects
dc:subject × 13Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36167